Acute respiratory infections (ARIs) are infections of the airways or lungs caused by viruses, bacteria, or occasionally other microorganisms, and they rank among the most common reasons people seek medical care worldwide. Viruses account for the majority of cases, though bacterial infections drive a disproportionate share of severe illness and death. The overlap between viral and bacterial symptoms makes ARIs surprisingly tricky to manage, and the consequences of getting the distinction wrong ripple from unnecessary antibiotic prescriptions all the way to delayed treatment of life-threatening pneumonia.
What Causes Most Acute Respiratory Infections
Viruses cause the bulk of ARIs. In a study of over 3,400 ARI patients older than five in rural Kenya, influenza A was the most commonly detected virus at about 22% of cases, followed by respiratory syncytial virus (RSV) at 8%, influenza B at 6%, and human metapneumovirus at 5%.1PLoS ONE. Etiology and Incidence of Viral and Bacterial Acute Respiratory Illness among Older Children and Adults in Rural Western Kenya, 2007–2010 Rhinoviruses, which cause most common colds, are responsible for an enormous number of mild upper respiratory infections as well. SARS-CoV-2 added another major viral cause starting in 2020. In general, the viral share of ARI cases significantly outweighs the bacterial share, though co-infections are not rare.
Among bacteria, Streptococcus pneumoniae (the pneumococcus) stands out. It is the leading cause of community-acquired pneumonia, middle-ear infections, and bacterial meningitis, and its success partly stems from its ability to persist harmlessly in the nose and throat before spreading to other sites when the opportunity arises.2ASM Journals / Microbiology Spectrum. Streptococcus pneumoniae: Invasion and Inflammation In the Kenyan ARI cohort, S. pneumoniae was the most common bacterial pathogen, detected in about 16% of cases overall and in nearly a quarter of hospitalized patients.1PLoS ONE. Etiology and Incidence of Viral and Bacterial Acute Respiratory Illness among Older Children and Adults in Rural Western Kenya, 2007–2010 Other bacterial culprits include Haemophilus influenzae, Staphylococcus aureus, and a group sometimes called “atypical” pathogens. These atypical bacteria, such as Mycoplasma pneumoniae and Legionella, lack a conventional cell wall or live inside host cells, which makes them naturally resistant to certain antibiotics and harder to detect with standard culture methods.3PubMed. Atypical pneumonia: Pathophysiology, diagnosis, and treatment
How Respiratory Viruses Get Inside Your Cells
Each respiratory virus has its own way of latching onto and entering the cells lining your airways. Influenza viruses use a surface protein called hemagglutinin to bind to sialic acid molecules on the surface of airway cells, which kicks off the infection cycle. A second surface protein, neuraminidase, then cleaves those same sialic acids to free newly made virus particles so they can spread to neighboring cells.4PubMed Central. Influenza Hemagglutinin and Neuraminidase: Yin⁻Yang Proteins Coevolving to Thwart Immunity The balance between these two proteins matters clinically because antiviral drugs like oseltamivir (Tamiflu) work by blocking neuraminidase, trapping new viruses on the cell surface.
Rhinoviruses, the most prolific cold viruses, take a different approach. About 90% of rhinovirus strains enter cells by binding to a molecule called ICAM-1 on the surface of airway epithelial cells.5Journal of Biological Chemistry. Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription Rhinovirus infection then triggers the cell to produce even more ICAM-1 on its surface, effectively rolling out the welcome mat for additional virus particles. People with allergies may be especially vulnerable: allergen exposure independently increases ICAM-1 levels on nasal cells, which could explain why allergy sufferers seem to catch more colds.6PubMed Central. Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection?
SARS-CoV-2 uses yet another receptor, ACE2, which sits on the surface of cells in the lungs, heart, and kidneys.7PubMed Central. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection ACE2 is most abundant in the nasal lining, particularly on ciliated cells, and decreases deeper into the lungs. That gradient helps explain why COVID-19 often starts in the nose and throat before progressing to the lower airways in severe cases.8Nature Reviews Molecular Cell Biology. Mechanisms of SARS-CoV-2 entry into cells
Why Respiratory Infections Make You Feel So Awful
Most of the misery from a respiratory infection comes not from the virus itself but from your immune system’s response. When a virus infects airway cells, those cells release signaling molecules called cytokines and chemokines that recruit immune cells to the site of infection. This inflammatory cascade produces the familiar constellation of symptoms: fever, sore throat, congestion, and fatigue. In severe cases, the immune response can overshoot, producing what researchers call a cytokine storm, a runaway inflammatory reaction that can damage the lungs and other organs and push patients toward respiratory failure.9PubMed Central. The critical impacts of cytokine storms in respiratory disorders
Cough deserves special mention because it is the symptom that often lingers longest and drives the most clinic visits. Viral infection triggers cough through several overlapping mechanisms: increased production of inflammatory neuropeptides and leukotrienes, changes in the sensitivity of cough-triggering nerve receptors, excess mucus production, and postnasal drip stimulating the throat.10PubMed Central. Cough and viruses in airways disease: mechanisms 11PubMed Central. Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough: New Insights for Clinical Practice The result is that cough reflex sensitivity remains heightened for days or even weeks after the virus has cleared, which is why you can still be coughing long after other symptoms have resolved.12PubMed Central. Effect of viral upper respiratory tract infection on cough reflex sensitivity
RSV causes a particularly distinctive form of damage in the lower airways. In severe cases, the virus triggers debris from dead epithelial and inflammatory cells to mix with mucus and fibrin, physically plugging the small airways. Swollen lymphoid tissue around the bronchioles adds to the obstruction.13Modern Pathology. The histopathology of fatal untreated human respiratory syncytial virus infection This is why RSV bronchiolitis in infants often sounds so alarming, with wheezing and visible effort with each breath: the baby’s tiny airways are physically clogged.
Telling Viral from Bacterial Infections
Distinguishing a viral ARI from a bacterial one remains one of the most persistent challenges in everyday medicine, and getting it wrong has real consequences in both directions. The clinical signs overlap heavily. Fever, sore throat with swollen lymph nodes, tonsillar enlargement, and the absence of cough tend to point more toward a bacterial cause, while cough, conjunctivitis, hoarseness, and diarrhea are more consistent with viral illness.14Family Practice and Palliative Care. Clinical scoring for distinction of bacterial and viral upper respiratory tract infections of children But these rules of thumb are far from reliable on their own.
Laboratory tests have gotten considerably better. Multiplex PCR panels, which can simultaneously test for dozens of pathogens from a single nasal swab, show very high accuracy for most common respiratory viruses, with sensitivity above 90% for influenza and specificity above 96%.15PubMed Central. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis 16PubMed Central. Diagnostic accuracy of point-of-care tests for acute respiratory infection: a systematic review of reviews Rapid antigen tests for influenza, RSV, and SARS-CoV-2, the kind you can run at the bedside or even at home, are slightly less sensitive but still useful, especially when viral loads are high.17PubMed. Diagnostic accuracy of a rapid antigen triple test (SARS-CoV-2, respiratory syncytial virus, and influenza) using anterior nasal swabs versus multiplex RT-PCR in children in an emergency department
A newer category of diagnostics tries to solve the problem from the host side rather than hunting for the pathogen. One approach combines two blood markers, MxA (a protein the body produces in response to viral infection) and CRP (a general inflammation marker that tends to spike higher in bacterial infections). In a multicenter study of 520 patients with febrile respiratory infections, this combined assay reached about 93% sensitivity and 88% specificity for identifying bacterial infections compared to a comprehensive reference testing panel.18Clinical Infectious Diseases. A Rapid Test to Differentiate Viral From Bacterial Infections: Searching for the Holy Grail An even more experimental approach uses a two-gene “host RNA signature” from a blood sample. In a validation study, this signature correctly identified all 23 children with confirmed bacterial infections and 27 of 28 with confirmed viral infections.19JAMA. Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children These host-response tests are not yet routine, but they represent a promising direction for reducing unnecessary antibiotic use.
Treatment and the Antibiotic Problem
For most viral ARIs, treatment is supportive: rest, fluids, fever reducers, and time. Specific antivirals exist for a few viruses. Oseltamivir targets influenza neuraminidase, and nirmatrelvir-ritonavir (Paxlovid) blocks SARS-CoV-2 replication. Timing matters a great deal with these drugs. A retrospective study of hospitalized COVID-19 patients found that starting Paxlovid roughly three days after symptom onset offered the best balance, reducing overall infectiousness by about 12%. Starting earlier actually raised the risk of a post-treatment viral rebound without meaningfully improving outcomes, while waiting longer than five days reduced the drug’s ability to cut peak viral shedding.20PubMed Central. A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients A similar principle holds for oseltamivir against flu: the earlier within the first 48 hours, the better.
Bacterial ARIs require antibiotics, but the trouble is that antibiotics end up being prescribed for viral infections far too often. An analysis of outpatient antibiotic prescribing in France found that lower respiratory tract infections accounted for about 40% of all antibiotic use during the cold season, and roughly 17% of that total was attributable to viral infections rather than bacterial ones. In children, viral lower respiratory infections drove an estimated 38% of outpatient antibiotic prescriptions, with bronchiolitis alone accounting for about half of antibiotic use in young children.21PubMed. Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017 These prescriptions do nothing for the patient and contribute to antimicrobial resistance, which is why better point-of-care diagnostics for distinguishing viral from bacterial infections are so actively pursued.
When a Viral Infection Opens the Door to Bacteria
One of the more dangerous patterns in respiratory illness is a secondary bacterial infection that develops in the wake of a viral one, particularly after influenza. The virus damages the epithelial lining of the lungs and suppresses several arms of the immune response, while simultaneously making more nutrients available for bacterial growth.22Journal of Infection and Public Health. PostInfluenza bacterial infections: Epidemiology, mechanistic insights and emerging treatment approaches The combination creates a window of vulnerability, usually in the days following the peak of viral illness, during which bacteria like S. pneumoniae and S. aureus can invade the compromised airways and cause a pneumonia that is often more severe than either infection alone.23PubMed Central. Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells
The classic warning sign is a patient who seems to be recovering from the flu and then takes a sudden turn for the worse: new fever, worsening cough, shortness of breath. This “double hit” of viral-then-bacterial illness has contributed substantially to excess deaths during influenza pandemics throughout history. Clinicians watching a flu patient deteriorate around day five or six are trained to think about superinfection and often start empiric antibiotics while awaiting cultures.
Why Children Are Hit Harder
Young children, especially infants, are disproportionately affected by ARIs, and the reasons go beyond their immature immune systems. Their anatomy works against them in several ways. Infants between about two and six months are preferential nasal breathers, meaning a stuffed nose is not just uncomfortable but can genuinely compromise their breathing.24PubMed. Structural and functional development in airways throughout childhood: Children are not small adults Their airways are narrower, their chest walls are more compliant (floppy), and the gas exchange surface of their lungs is still developing. At the same time, infants have a metabolic oxygen demand more than double that of adults, so when something compromises their breathing, oxygen levels drop much faster.25PubMed Central. Developmental respiratory physiology Alveolarization, the process of forming the tiny air sacs where gas exchange happens, continues well beyond birth and into adolescence, which means a young child literally has fewer functional air sacs to work with during an infection.24PubMed. Structural and functional development in airways throughout childhood: Children are not small adults
These anatomical realities help explain why RSV bronchiolitis can be a minor nuisance in an adult but a medical emergency in a two-month-old. They also explain why younger children have higher rates of hospitalization from influenza and why pediatric emergency departments fill up predictably every winter respiratory season.
Protecting Infants Before They Can Be Vaccinated
For RSV, a major threat to young infants, two new immunoprophylactic strategies have changed the landscape. The first is maternal vaccination: a vaccine given to pregnant women induces the mother’s immune system to produce high levels of RSV-neutralizing antibodies, which then cross the placenta and protect the newborn from birth. In phase III clinical data, maternal RSV vaccination showed efficacy up to about 82% against severe RSV lower respiratory tract infection in the infant’s first 90 days of life.26PubMed Central. Maternal RSV immunization: clinical efficacy, immunological mechanisms and public health implications for preventing infant lower respiratory tract infection
The second approach is long-acting monoclonal antibodies such as nirsevimab, given directly to the infant. These bypass the variability inherent in maternal immune responses and provide standardized, season-long protection regardless of the baby’s gestational age at birth, which is especially relevant for preterm infants who may not have received enough antibodies through the placenta.27PubMed Central. Respiratory Syncytial Virus Prophylaxis: Maternal Vaccination or Long-Acting Monoclonal Antibodies? A Brief Narrative Review of Current Status In practice, families and clinicians now have a choice between these two strategies, and the decision often depends on timing: if the mother can be vaccinated in the right gestational window before RSV season, maternal vaccination integrates easily into existing prenatal care. If that window is missed or the baby is born preterm, a monoclonal antibody injection for the infant fills the gap.
How Weather Shapes Respiratory Infection Seasons
The strong seasonality of respiratory viruses, especially influenza and RSV, is partly driven by temperature and humidity. Laboratory experiments with influenza show that the steepest change in how well the virus survives in airborne droplets occurs between about 30% and 50% relative humidity at roughly room temperature. Increasing both temperature and humidity reduces virus survival and transmission, and the effects appear to add together.28PubMed Central. Humidity and respiratory virus transmission in tropical and temperate settings This helps explain why respiratory infections peak during cold, dry winter months in temperate climates: indoor heating drops humidity to levels that favor virus persistence in the air, while cold outdoor air does the same.
In tropical climates, the seasonal pattern is different and often linked to rainy seasons, when people cluster indoors more. The upshot for individuals is straightforward: keeping indoor humidity in a moderate range (roughly 40% to 60%) and ensuring good ventilation are among the simplest environmental measures you can take during respiratory virus season.
Your Airway Microbiome as a Defense Layer
An emerging area of research suggests that the community of bacteria normally living in your nose and throat plays a meaningful role in protecting against respiratory infections. Certain commensal bacteria in the nasal cavity, particularly Corynebacterium and Dolosigranulum, appear to directly inhibit the growth and virulence of common lung pathogens, and their abundance in the upper airway correlates with lower rates of respiratory tract infections in clinical studies. Meanwhile, anaerobic bacteria common in the mouth and lungs, such as Prevotella and Veillonella, are associated with better outcomes during pneumonia and can activate several immune defense pathways in the lower airway.29PubMed Central. Insights into the role of the respiratory tract microbiome in defense against bacterial pneumonia
This research is still in its early stages, but it raises an interesting practical question: could disrupting your normal airway bacteria, through frequent antibiotic use, for instance, make you more susceptible to respiratory infections? The evidence is suggestive but not yet conclusive. What is clear is that the old view of healthy airways as sterile was wrong. Your respiratory tract hosts a complex microbial community, and when that community is balanced, it appears to add a layer of defense that works alongside your immune system.
Long-Term Lung Damage After Severe Infections
Most people recover fully from an ARI within a few weeks, but severe lower respiratory infections can leave lasting marks on lung tissue. Pulmonary fibrosis, in which scar tissue replaces normal lung tissue, has been documented after several types of severe pneumonia. In a study of 12 patients who survived acute Legionnaires’ disease pneumonia, five developed pulmonary fibrosis. Four of those five deteriorated rapidly and died from respiratory failure despite having received appropriate antibiotics during the acute phase, while the fifth survived but with permanent lung impairment.30PubMed. Pulmonary fibrosis following pneumonia due to acute Legionnaires’ disease. Clinical, ultrastructural, and immunofluorescent study The underlying process involves disruption of the delicate alveolar lining and basement membranes, followed by abnormal collagen deposition.
Post-COVID lung fibrosis brought renewed attention to this issue, but the phenomenon is not unique to SARS-CoV-2. Any severe pneumonia that damages the alveolar architecture, whether caused by bacteria, viruses, or fungi, carries a risk of scarring. The patients most vulnerable to this outcome tend to be those who experienced the most intense inflammatory responses during the acute illness, which loops back to the cytokine storm phenomenon described earlier. For survivors of severe pneumonia who notice persistent shortness of breath or reduced exercise tolerance weeks after discharge, follow-up lung imaging and pulmonary function testing can help identify fibrosis early and guide rehabilitation.